The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations

D Tripathi, G Therapondos, E Jackson, D N Redhead, P C Hayes, D Tripathi, G Therapondos, E Jackson, D N Redhead, P C Hayes

Abstract

Background: The transjugular intrahepatic portosystemic stent shunt (TIPSS) is effective in the management of both oesophageal and gastric variceal bleeding. Although it has been reported that gastric varices can bleed at pressures of < or = 12 mm Hg, this phenomenon has been little studied in the clinical setting.

Aims: To assess the efficacy of TIPSS on rebleeding and mortality following gastric and oesophageal variceal bleeding, and the importance of portal pressure in both groups.

Methods: Forty eligible patients who had bled from gastric varices and 232 from oesophageal varices were studied. Patients were also subdivided into those whose portal pressure gradients (PPG) prior to TIPSS were < or = 12 mm Hg (group 1) and >12 mm Hg (group 2).

Results: There was no difference in Child-Pugh score, age, sex, or alcohol related disease between patients bleeding from gastric or oesophageal varices. Patients who bled from gastric varices had a lower PPG pre-TIPSS (15.8 (0.8) v 21.44 (0.4) mm Hg; p<0.001). There was no difference in the rebleeding rate (20.0% v 14.7%; NS). There was a significant difference (p<0.05) in favour of the gastric varices group in the one year mortality (30.7% v 38.7%) and five year mortality (49.5% v 74.9%), particularly in those patients in group 2. Gastric variceal bleeding accounted for significantly more cases in group 1 than in group 2 (36.8% v 10.2%; p<0.001). Most patients in group 2 who rebled had a PPG post-TIPSS of >7 mm Hg.

Conclusions: TIPSS is equally effective in the prevention of rebleeding following gastric and oesophageal variceal bleeding. A significant proportion of gastric varices bleed at a PPG < or = 12 mm Hg. The improved mortality in patients with gastric variceal bleeding is seen only in those that bleed at a PPG >12 mm Hg, and warrants further study.

Figures

Figure 1
Figure 1
Kaplan Meier graph of rebleeding for all patients who bled from gastric and oesophageal varices treated with a transjugular intrahepatic portosystemic stent shunt.
Figure 2
Figure 2
Kaplan Meier graph of survival for all patients who bled from gastric and oesophageal varices treated with a transjugular intrahepatic portosystemic stent shunt.
Figure 3
Figure 3
Kaplan Meier graph of survival for all patients who bled from gastric and oesophageal varices at a portal pressure gradient of greater than 12 mm Hg.

References

    1. Williams SG, Westaby D. Management of variceal haemorrhage. BMJ 1994;308:1213–17.
    1. Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–24.
    1. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056–9.
    1. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401–7.
    1. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343–9.
    1. Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 1991;13:274–8.
    1. Ramond MJ, Valla D, Gotlib JP, et al. Endoscopic obturation of esophagogastric varices with bucrylate. I. Clinical study of 49 patients. Gastroenterol Clin Biol 1986;10:575–9.
    1. Przemioslo RT, McNair A, Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci 1999;44:778–81.
    1. Williams SG, Peters RA, Westaby D. Thrombin—an effective treatment for gastric variceal haemorrhage. Gut 1994;35:1287–9.
    1. Albillos A, Ruiz dA. “Salvage” transjugular intrahepatic portosystemic shunt: gastric fundal compared with esophageal variceal bleeding. Gastrointest Endosc 1999;50:294–5.
    1. Barange K, Peron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30:1139–43.
    1. Stanley AJ, Jalan R, Ireland HM, et al. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997;11:171–6.
    1. Jalan R, Redhead DN, Forrest EH, et al. Relationship between directly measured portal pressure gradient and variceal hemorrhage. Am J Gastroenterol 1995;90:1994–6.
    1. Watanabe K, Kimura K, Matsutani S, et al. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988;95:434–40.
    1. Chalmers N, Redhead DN, Simpson KJ, et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol 1992;46:166–9.
    1. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000;46(suppl 3–4):iii1–15.
    1. Takeuchi M, Nakai Y, Syu A, et al. Endoscopic ligation of gastric varices. Lancet 1996;348:1038.
    1. Lee GH, Kim JH, Lee KJ, et al. Life-threatening intraabdominal arterial embolization after histoacryl injection for bleeding gastric ulcer. Endoscopy 2000;32:422–4.
    1. See A, Florent C, Lamy P, et al. Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients. Gastroenterol Clin Biol 1986;10:604–7.
    1. Yang WL, Tripathi D, Therapondos G, et al. Thrombin in gastric varices. Gut 2001;48(suppl 1):393.
    1. Henderson JM, Nagle A, Curtas S, et al. Surgical shunts and tips for variceal decompression in the 1990s. Surgery 2000;128:540–7.
    1. Orozco H, Mercado MA, Granados GJ, et al. Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg 1997;3:475–80.
    1. Thomas PG, D'Cruz AJ. Distal splenorenal shunting for bleeding gastric varices. Br J Surg 1994;81:241–4.
    1. Krahenbuhl L, Seiler CA, Buchler MW. Variceal hemorrhage in portal hypertension: role of surgery in the acute and elective situation. Schweiz Med Wochenschr 1999;129:631–8.
    1. Chao Y, Lin HC, Lee FY, et al. Hepatic hemodynamic features in patients with esophageal or gastric varices. J Hepatol 1993;19:85–9.
    1. Chau TN, Patch D, Chan YW, et al. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981–7.
    1. Rees CJ, Nylander DL, Thompson NP, et al. Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver 2000;20:253–6.
    1. Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995;2:123–8.
    1. Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 1982;82:968–73.
    1. Stanley AJ, Robinson I, Forrest EH, et al. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM 1998;91:19–25.
    1. Patch D, Armonis A, Sabin C, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999;44:264–9.
    1. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626–31.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren